US Marines studying mindfulness-based training
The U.S. Marine Corps,
known for turning out some of the military's toughest warriors, is
studying how to make its troops even tougher through meditative
practices, yoga-type stretching and exercises based on mindfulness.
Facing a record suicide
rate and thousands of veterans seeking treatment for post-traumatic
stress, the military has been searching for ways to reduce strains on
service members burdened with more than a decade of fighting in Iraq and
Afghanistan.
PTSD results from exposure to events that involve the threat of death or loss of psychological integrity. Mindfulness is an attentive awareness of the reality of things, especially the present moment and is increasingly practiced in psychology to alleviate a variety of mental and physical conditions. Psilocybin decreases activity in the brain that provides our sense of separateness, helping to remove the optical delusion that we are individuals struggling alone in the universe.
Einstein Quote
"A human being is a part of the whole, called by us, "Universe," a part limited in time and space. He experiences himself, his thoughts and feelings as something separated from the rest -- a kind of optical delusion of his consciousness.
This delusion is a kind of prison for us, restricting us to our personal desires and to affection for a few persons nearest to us. Our task must be to free ourselves from this prison by widening our circle of compassion to embrace all living creatures and the whole of nature in its beauty.
Nobody is able to achieve this completely, but the striving for such achievement is in itself a part of the liberation and a foundation for inner security." Albert Einstein - (1879-1955)
Psilocybin should only be taken with a spiritual mindset in a supportive environment.
Be sure to continue reading with "Older Posts" at bottom of page.
Sunday, January 20, 2013
Monday, January 14, 2013
Psilocybin use in end of life care: Journal of the National Cancer Institute
Macready N. J Natl Cancer Inst. 2012 Nov 7;104(21):1619-20. Epub 2012 Oct 25. No abstract available. PMID: 23104218
Cited by (Google Scholar)
Cited by (Google Scholar)
Results of this ongoing study at New York University that has involved 12 patients given 0.3mg/kg of psilocybin. Study goal is 32 patients. Patients received 9 months of psychotherapy as well as psilocybin.
· all subjects experienced rapid clinical improvement (Psychiatric)
· there was significant reduction or resolution of death anxiety
· there was a decrease in depression/anxiety in general
· patients became more spiritual/philosophical and more connected with others
· they reported feeling interconnected with other forms of energy and that their consciousness was a part of a larger consciousness
· they felt connected to transcendental forces and a sense of sacredness
Dr. Anthony Bossis stated "Every patient I've worked with says the drug has allowed them to live more fully in the present, to be less concerned with yesterday and tomorrow and whether tomorrow will bring more suffering."
"One patient, now deceased, said he realized that consciousness doesn't end, it doesn't die, it continuous and that his body is one aspect of life, that physical death is part of the life experience, but there is a broader continuum."
Wednesday, January 2, 2013
Self-Transcendence
Link to a slideshow that discusses varies aspects of Self-Transcendence. Some of the links are to videos that are related directly or indirectly to Self-Transcendence. Others are links to scientific articles or sections of various texts.
Self-Transcendence
Tuesday, January 1, 2013
Factor Analysis of the Mystical Experience Questionnaire: A Study of Experiences Occasioned by the Hallucinogen Psilocybin
Factor Analysis of the Mystical Experience Questionnaire: A Study of Experiences Occasioned by the Hallucinogen Psilocybin
Katherine A. MacLean, Jeannie-Marie S. Leoutsakos, Matthew W. Johnson, Roland R. Griffiths. Journal for the Scientific Study of Religion. Vol 51 Issue 4. Article first published online: 4 Dec 2012
A large body of historical evidence describes the use of
hallucinogenic compounds, such as psilocybin mushrooms, for religious
purposes. But few scientific studies have attempted to measure or
characterize hallucinogen-occasioned spiritual experiences. The present
study examined the factor structure of the Mystical Experience
Questionnaire (MEQ), a self-report measure that has been used to assess
the effects of hallucinogens in laboratory studies. Participants (N =
1,602) completed the 43-item MEQ in reference to a mystical or profound
experience they had had after ingesting psilocybin. Exploratory factor
analysis of the MEQ retained 30 items and revealed a four-factor
structure covering the dimensions of classic mystical experience: unity,
noetic quality, sacredness (F1); positive mood (F2); transcendence of
time/space (F3); and ineffability (F4). MEQ factor scores showed good
internal reliability and correlated with the Hood Mysticism Scale,
indicating convergent validity. Participants who endorsed having had a
mystical experience on psilocybin, compared to those who did not, had
significantly higher factor scores, indicating construct validity. The
four-factor structure was confirmed in a second sample (N = 440) and
demonstrated superior fit compared to alternative models. The results
provide initial evidence of the validity, reliability, and factor
structure of a 30-item scale for measuring single,
hallucinogen-occasioned mystical experiences, which may be a useful tool
in the scientific study of mysticism.
Subscribe to:
Posts (Atom)